Paper40140539
Sporogen-AO1 inhibits eukaryotic translation elongation.
Machida K and 4 others. J Antibiot (Tokyo), 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Sporogen-AO1 inhibits eukaryotic translation elongation. Papers, record 40140539. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40140539
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Protein Biosynthesis | Major topic |
| Peptide Chain Elongation, Translational | Major topic |
| Protein Synthesis Inhibitors | Major topic |
| Humans | |
| HeLa Cells | |
| Cell-Free System | |
| Ribosomes | |
| Cycloheximide | |
| Escherichia coli |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 22H02612 | MEXT | Japan Society for the Promotion of Science (JSPS) | PubMed | ||
| 21H05277 | MEXT | Japan Society for the Promotion of Science (JSPS) | PubMed | ||
| 21H02468 | MEXT | Japan Society for the Promotion of Science (JSPS) | PubMed | ||
| 21H05727 | MEXT | Japan Society for the Promotion of Science (JSPS) | PubMed | ||
| 21gm1410008s0101 | Japan Agency for Medical Research and Development (AMED) | PubMed |
Source PubMed
References14
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20204847 | Cell-free protein synthesis systems with extracts from cultured human cells. | Methods Mol Biol | 2010 | https://conductscience.org/library/papers/20204847 | PubMed |
| 2 | 18814849 | A human cell-derived in vitro coupled transcription/translation system optimized for production of recombinant proteins. | Protein Expr Purif | 2008 | https://conductscience.org/library/papers/18814849 | PubMed |
| 3 | 38293767 | High-throughput screening for a SARS-CoV-2 frameshifting inhibitor using a cell-free protein synthesis system. | Biotechniques | 2024 | https://conductscience.org/library/papers/38293767 | PubMed |
| 4 | 30487538 | Dynamic interaction of poly(A)-binding protein with the ribosome. | Sci Rep | 2018 | https://conductscience.org/library/papers/30487538 | PubMed |
| 5 | 32053165 | Reconstitution of yeast translation elongation and termination in vitro utilizing CrPV IRES-containing mRNA. | J Biochem | 2020 | https://conductscience.org/library/papers/32053165 | PubMed |
| 6 | 25258322 | A translation system reconstituted with human factors proves that processing of encephalomyocarditis virus proteins 2A and 2B occurs in the elongation phase of translation without eukaryotic release factors. | J Biol Chem | 2014 | https://conductscience.org/library/papers/25258322 | PubMed |
| 7 | 11297676 | Analysis of the aphthovirus 2A/2B polyprotein 'cleavage' mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal 'skip'. | J Gen Virol | 2001 | https://conductscience.org/library/papers/11297676 | PubMed |
| 8 | 19109895 | Translation initiation on mammalian mRNAs with structured 5'UTRs requires DExH-box protein DHX29. | Cell | 2008 | https://conductscience.org/library/papers/19109895 | PubMed |
| 9 | 8943341 | Canonical eukaryotic initiation factors determine initiation of translation by internal ribosomal entry. | Mol Cell Biol | 1996 | https://conductscience.org/library/papers/8943341 | PubMed |
| 10 | 9420332 | A prokaryotic-like mode of cytoplasmic eukaryotic ribosome binding to the initiation codon during internal translation initiation of hepatitis C and classical swine fever virus RNAs. | Genes Dev | 1998 | https://conductscience.org/library/papers/9420332 | PubMed |
| 11 | 12533507 | Translation elongation after assembly of ribosomes on the Cricket paralysis virus internal ribosomal entry site without initiation factors or initiator tRNA. | Genes Dev | 2003 | https://conductscience.org/library/papers/12533507 | PubMed |
| 12 | 32428051 | Natural products targeting the elongation phase of eukaryotic protein biosynthesis. | Nat Prod Rep | 2020 | https://conductscience.org/library/papers/32428051 | PubMed |
| 13 | 22850420 | Translation regulation as a therapeutic target in cancer. | Cancer Res | 2012 | https://conductscience.org/library/papers/22850420 | PubMed |
| 14 | 31867270 | Targeting of the Eukaryotic Translation Initiation Factor 4A Against Breast Cancer Stemness. | Front Oncol | 2019 | https://conductscience.org/library/papers/31867270 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40140539
GET https://conductscience.org/api/papers/v1/40140539/authors